| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| diacerein | arachidonate 5-lipoxygenase | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 1a2 | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 2c9 | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 2d6 | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 2e1 | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 3a subfamily | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 3a subfamily | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 3a subfamily | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | cytochrome p450 3a subfamily | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | interleukin-1 beta | NA | Successful target | TTD , DGIDB | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
0.38 | phase 4 | unknown |
| diacerein | oxysterols receptor lxr-beta | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| diacerein | oxysterols receptor lxr-alpha | small molecule | NA | drugbank | Degenerative polyarthritis[MeSHID:D010003] Knee[MeSHID:D007717] Bone structure of ischium[MeSHID:D007512] Affect (mental function)[MeSHID:D000339] Hip structure[MeSHID:D006615] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||